General Information of the Compound
Compound ID
CP0072340
Compound Name
N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide
    Show/Hide
Synonyms
I-kappaB kinase beta inhibitor (dermatological, atopic dermatitis/acne), Institute of Medicinal MolecularDesign
I-kappaB kinase beta inhibitor (oral, rheumatoid arthritis/osteoporosis), IMMD
IKK-beta inhibitor (dermatological, atopic dermatitis/acne), IMMD
IL-6 release inhibitor (oral, rheumatoid arthritis/osteoporosis), IMMD
IMD-0354
IMD-2560
IMD-2560)
    Show/Hide
Structure
Formula
C15H8ClF6NO2
Molecular Weight
383.675
Canonical SMILES
Oc1ccc(Cl)cc1C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25)
    Show/Hide
InChIKey
CHILCFMQWMQVAL-UHFFFAOYSA-N
Physicochemical Property
logP
5.3355
Rotatable Bonds
2
Heavy Atom Count
25
Polar Areas
49.33
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5081913
SID: 14804810
ChEMBL ID
CHEMBL536151
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00877, Inhibitor of nuclear factor kappa-B kinase subunit beta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000001 Jurkat Homo sapiens (Human)  1
1
IC50 = 218 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 > 100000 nM
Protein ID: PT04758, P2X purinoceptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  4
1
IC50 = 19.2 nM
   TI
   LI
   LO
   TS
2
IC50 = 570 nM
   TI
   LI
   LO
   TS
3
IC50 = 3640 nM
   TI
   LI
   LO
   TS
4
IC50 = 4730 nM
   TI
   LI
   LO
   TS
Protein ID: PT04148, P2X purinoceptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Protein ID: PT03393, P2X purinoceptor 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Protein ID: PT02908, P2X purinoceptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 156 nM
   TI
   LI
   LO
   TS
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 175 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( IMD-0354 )
Drug Name IMD-0354
Company Institute of Medicinal Molecular Design Inc
Indication
Acne vulgaris
Phase 1
Target(s)
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
Inhibitor